A5009159473- Infective Endocarditis Diagnosis and Management
- Streptococcal Infections and Treatments
- Acute Myocardial Infarction Research
- Migraine and Headache Studies
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Kawasaki Disease and Coronary Complications
- Blood Pressure and Hypertension Studies
- Cardiac Imaging and Diagnostics
- Lipoproteins and Cardiovascular Health
- Cardiac Valve Diseases and Treatments
- Antimicrobial Resistance in Staphylococcus
- Global Public Health Policies and Epidemiology
- Antiplatelet Therapy and Cardiovascular Diseases
- Otolaryngology and Infectious Diseases
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Coronary Artery Anomalies
- Coronary Interventions and Diagnostics
- Healthcare cost, quality, practices
- Cardiovascular Health and Risk Factors
- Pharmaceutical studies and practices
- Bacterial Identification and Susceptibility Testing
- Congenital Heart Disease Studies
- Health Promotion and Cardiovascular Prevention
The University of Texas Southwestern Medical Center
1970-2023
Instituto Nacional de Cardiologia
2023
American Heart Association
2004-2020
The Geneva Association
2017-2020
Beijing Institute of Water
2017
Beijing Anzhen Hospital
2017
Capital Medical University
2017
Peking University First Hospital
2017
Peking University
2017
Fudan University
2017
In 1998, the American Heart Association convened Prevention Conference V to examine strategies for identification of high-risk patients who need primary prevention. Among discussed was measurement markers inflammation.1 The concluded that “many these (including inflammatory markers) are not yet considered applicable routine risk assessment because of: (1) lack standardization, (2) consistency in epidemiological findings from prospective studies with endpoints, and (3) evidence novel marker...
Background— The purpose of this statement is to update the recommendations by American Heart Association (AHA) for prevention infective endocarditis that were last published in 1997. Methods and Results— A writing group was appointed AHA their expertise treatment endocarditis, with liaison members representing Dental Association, Infectious Diseases Society America, Academy Pediatrics. reviewed input from national international experts on endocarditis. document reflect analyses relevant...
HomeCirculationVol. 113, No. 19AHA/ACC Guidelines for Secondary Prevention Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Background— Kawasaki disease is an acute self-limited vasculitis of childhood that characterized by fever, bilateral nonexudative conjunctivitis, erythema the lips and oral mucosa, changes in extremities, rash, cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop ∼15% to 25% untreated children may lead ischemic heart sudden death. Methods Results— A multidisciplinary committee experts was convened revise American Heart Association recommendations for diagnosis, treatment,...
Background— Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity mortality. The continuing evolution of antimicrobial resistance among common pathogens cause creates additional therapeutic issues for physicians to manage this potentially life-threatening illness. Methods Results— This work represents the third iteration an “treatment” document developed by American Heart Association...
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result an outside relationship
Background. Kawasaki disease is an acute self-limited vasculitis of childhood that characterized by fever, bilateral nonexudative conjunctivitis, erythema the lips and oral mucosa, changes in extremities, rash, cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop ∼15% to 25% untreated children may lead ischemic heart sudden death. Methods Results. A multidisciplinary committee experts was convened revise American Heart Association recommendations for diagnosis, treatment,...
Despite improvements in cardiovascular implantable electronic device (CIED) design, application of timely infection control practices, and administration antibiotic prophylaxis at the time placement, CIED infections continue to occur can be life-threatening. This has prompted study all aspects infections. Recognizing recent advances our understanding epidemiology, risk factors, microbiology, management, prevention infections, American Heart Association commissioned this scientific statement...
A link between oral health and cardiovascular disease has been proposed for more than a century. Recently, concern about possible links periodontal (PD) atherosclerotic vascular (ASVD) intensified is driving an active field of investigation into association causality. The 2 disorders share several common risk factors, including cigarette smoking, age, diabetes mellitus. Patients providers are increasingly presented with claims that PD treatment strategies offer ASVD protection; these often...
HomeCirculationVol. 107, No. 11American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood
HomeCirculationVol. 104, No. 13AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
Acute rheumatic fever remains a serious healthcare concern for the majority of world's population despite its decline in incidence Europe and North America. The goal this statement was to review historic Jones criteria used diagnose acute context current epidemiology disease update those also take into account recent evidence supporting use Doppler echocardiography diagnosis carditis as major manifestation fever.To achieve goal, American Heart Association's Council on Cardiovascular Disease...
Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis GAS pharyngitis best combining clinical judgment with diagnostic test results, the criterion standard which throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) choice, because it cost-effective, has a narrow spectrum activity, long-standing proven efficacy,...